Rafferty Asset Management, LLC Spring Works Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 138,097 shares of SWTX stock, worth $5.08 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

138,097

Previous 155,882 11.41%

Holding current value

$5.08 Million

Previous $5.87 Million 24.66%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$32.04 - $42.76 $569,831 - $760,486	-17,785 Reduced 11.41%	138,097 $4.42 Million
Q2 2024 Aug 13, 2024	SELL	$36.06 - $47.62 $854,045 - $1.13 Million	-23,684 Reduced 13.19%	155,882 $5.87 Million
Q1 2024 May 13, 2024	BUY	$36.5 - $52.5 $1.29 Million - $1.85 Million	35,219 Added 24.4%	179,566 $8.84 Million
Q4 2023 Feb 13, 2024	SELL	$18.94 - $37.24 $667,388 - $1.31 Million	-35,237 Reduced 19.62%	144,347 $5.27 Million
Q3 2023 Nov 13, 2023	SELL	$23.12 - $31.38 $1.42 Million - $1.92 Million	-61,227 Reduced 25.43%	179,584 $4.15 Million
Q2 2023 Aug 11, 2023	BUY	$23.15 - $32.71 $508,883 - $719,031	21,982 Added 10.05%	240,811 $6.31 Million
Q1 2023 May 11, 2023	SELL	$24.97 - $34.05 $2.49 Million - $3.39 Million	-99,596 Reduced 31.28%	218,829 $5.63 Million
Q4 2022 Feb 13, 2023	BUY	$21.73 - $28.72 $1.61 Million - $2.13 Million	74,061 Added 30.31%	318,425 $8.28 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $1.68 Million - $2.76 Million	69,660 Added 39.87%	244,364 $6.97 Million
Q2 2022 Aug 12, 2022	BUY	$18.36 - $60.07 $1.54 Million - $5.04 Million	83,875 Added 92.34%	174,704 $4.3 Million
Q1 2022 May 13, 2022	BUY	$48.97 - $65.46 $760,895 - $1.02 Million	15,538 Added 20.64%	90,829 $5.13 Million
Q4 2021 Feb 10, 2022	BUY	$53.3 - $75.84 $1.58 Million - $2.25 Million	29,718 Added 65.21%	75,291 $4.67 Million
Q3 2021 Nov 10, 2021	BUY	$62.66 - $88.26 $867,402 - $1.22 Million	13,843 Added 43.63%	45,573 $2.89 Million
Q2 2021 Aug 10, 2021	SELL	$67.45 - $85.63 $722,726 - $917,525	-10,715 Reduced 25.24%	31,730 $2.62 Million
Q1 2021 May 10, 2021	BUY	$65.1 - $93.59 $2.16 Million - $3.11 Million	33,209 Added 359.56%	42,445 $3.12 Million
Q4 2020 Feb 10, 2021	SELL	$48.36 - $77.92 $361,926 - $583,153	-7,484 Reduced 44.76%	9,236 $670,000
Q3 2020 Nov 13, 2020	BUY	$36.14 - $51.99 $604,260 - $869,272	16,720 New	16,720 $797,000

Others Institutions Holding SWTX

# of Institutions

237

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.3B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Spring Works Therapeutics, Inc. Transaction History